FDA Approves First New Sunscreen Ingredient in Over Two Decades
FDA green lights 1st new sunscreen – The U.S. Food and Drug Administration has granted approval for bemotrizinol, a novel ultraviolet filter, marking the first such endorsement in more than 20 years. This decision, announced on Tuesday, allows the ingredient to be used in sunscreens for adults and children aged six months and above.
Ingredient Safety and Benefits
Bemotrizinol, a non-mineral chemical compound, offers enhanced stability in sunlight compared to current UVA and UVB filters. It resists degradation more effectively, potentially improving the longevity of sun protection. Dermatologists note that this ingredient is less readily absorbed into the bloodstream than others, though its long-term health effects remain under review.
“Bemotrizinol has been used safely in Europe for decades, and FDA’s action will increase competition and consumer confidence in sunscreen products,” said Robert F. Kennedy Jr., Secretary of the Department of Health and Human Services.
Industry and Advocacy Perspectives
Environmental Working Group (EWG) and other advocacy groups have sought FDA approval for bemotrizinol for years, emphasizing its role in addressing gaps in UVA protection. The agency’s determination classifies the ingredient as generally recognized as safe and effective (GRASE), aligning with international standards.
“This is a great day for American consumers and everyone who has fought to improve sunscreen options and close the UVA protection gap in U.S. sunscreens,” stated David Andrews, chief science officer at EWG.
Related Stories
Air Canada pilot arrested for flying without proper license
An NBA Finals with ‘too many superstars’: How the NY Knicks compose ‘celebrity row’
Nick Reiner files petition demanding trust fund money to pay for defense
